Effects of MDMA and intranasal oxytocin on social and emotional processing

Neuropsychopharmacology

Volumn 39, Issue 7, 2014, Pages 1654-1663

  Kirkpatrick, Matthew G ^a   Lee, Royce ^a   Wardle, Margaret C ^a   Jacob, Suma ^b   De Wit, Harriet ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Emotion; Humans; MDMA; Mood; Oxytocin; Social behavior

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; OXYTOCIN; PLACEBO; PSYCHEDELIC AGENT;

ADULT; ANGER; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT QUESTIONNAIRE; DRUG RESPONSE; EMOTION; EMOTIONAL PROCESSING; EMPATHY; EUPHORIA; FACIAL EXPRESSION; FEAR; FEMALE; HAPPINESS; HEART RATE; HUMAN; HUMAN EXPERIMENT; LIKERT SCALE; MALE; MEDICAL EXAMINATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUESTIONNAIRE; RECOGNITION; SELF REPORT; SOCIAL BEHAVIOR; SOCIAL BONDING; SOCIAL PROCESSING; SOCIAL STATUS; SYSTOLIC BLOOD PRESSURE; TASK PERFORMANCE; VISUAL ANALOG SCALE; DECISION MAKING; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; INTRANASAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; TIME; YOUNG ADULT;

ADMINISTRATION, INTRANASAL; ADULT; BLOOD PRESSURE; CHOICE BEHAVIOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EMOTIONS; FEMALE; HALLUCINOGENS; HEART RATE; HUMANS; LINEAR MODELS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; OXYTOCIN; QUESTIONNAIRES; SOCIAL BEHAVIOR; TIME FACTORS; YOUNG ADULT;

EID: 84900549394     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.12     Document Type: Article

References (60)

1. Abraham TT, Barnes AJ, Lowe RH, Kolbrich Spargo EA, Milman G, Pirnay SO et al (2009). Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humans. J Anal Toxicol 33: 439-446.
2. Bartz J, Simeon D, Hamilton H, Kim S, Crystal S, Braun A et al (2011a). Oxytocin can hinDer trust and cooperation in borDerline personality disorDer. Soc Cogn Affect Neurosci 6: 556-563.
3. Bartz JA,Zaki J,Bolger N,Ochsner KN,2011, Social effects of oxytocin in humans: Context and person matter, Trends Cogn Sci,15, 301-309.
4. Bedi G, Hyman D, De Wit H (2010). Is ecstasy anempathogenEffects of +/-3,4-methylenedioxymethamphetamine on prosocial feelings and iDentification of emotional states in others. Biol Psychiatry 1134-1140.
5. Bedi G, Phan KL, Angstadt M, De Wit H (2009). Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology (Berl) 207: 73-83.
6. Born J, Lange T, Kern W, McGregor GP, Bickel U, Fehm HL (2002). Sniffing neuropeptiDes: A transnasal approach to the human brain. Nat Neurosci 5: 514-516.
7. Bos PA, Panksepp J, Bluthe RM, Honk JV (2011). Acute effects of steroid hormones and neuropeptiDes on human social-emotional behavior: A review of single administration studies. Front Neuroendocrinol 33: 17-35.
8. Bravo GL (2001). What does MDMA feel like In: Holland J (ed). Ecstasy: The Complete GuiDe. A Comprehensive Look at the Risks and Benefits of MDMA. Park Street Press: Rochester, US.
9. Burkett JP, Young LJ (2012). The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction. Psychopharmacology (Berl) 224: 1-26.
10. Declerck CH, Boone C, Kiyonari T (2010). Oxytocin and cooperation unDer conditions of uncertainty: The modulating role of incentives and social information. Horm Behav 57: 368-374.
11. De Oliveira DC, Zuardi AW, Graeff FG, Queiroz RH, Crippa JA (2012). Anxiolytic-like effect of oxytocin in the simulated public speaking test. J Psychopharmacol 26: 497-504.
12. Di Simplicio M, Massey-Chase R, Cowen PJ, Harmer CJ (2009). Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers. J Psychopharm acol 23: 241-248.
13. Ditzen B, Schaer M, Gabriel B, BoDenmann G, Ehlert U, Heinrichs M (2009). Intranasal oxytocin increases positive communication and reduces cortisol levels during couple conflict. Biol Psychiatry 65: 728-731.
14. Domes G, Heinrichs M, Glascher J, Buchel C, Braus DF, Herpertz SC (2007a ). Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biol Psychiatry 62: 1187-1190.
15. Domes G, Heinrichs M, Michel A, Berger C, Herpertz SC (2007b ). Oxytocin improves " mind-reading" in humans. Biol Psychiatry 61: 731-733.
16. Domes G, Lischke A, Berger C, Grossmann A, Hauenstein K, Heinrichs M et al (2010). Effects of intranasal oxytocin on emotional face processing in women. Psychoneuroendocrinology 35: 83-93.
17. Doty P, De Wit H (1995). Effect of setting on the reinforcing and subjective effects of ethanol in social drinkers. Psychopharmacology (Berl) 118: 19-27.
18. Dumont GJ, Sweep FC, van Der Steen R, Hermsen R, DonDe rs AR, Touw DJ et al (2009). Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration. Soc Neurosci 4: 359-366.
19. Ekman P, Friese n WV (1976). Pictures of Facial Affect. Consulting Psychologists Press: Palo Alto, California.
20. Fischman MW, Foltin RW (1991). Utility of subjective-effects measurements in assessing abuse liability of drugs in humans. Br J Addict 86: 1563-1570.
21. Gimpl G, Fahrenholz F (2001). The oxytocin receptor system: Structure, function, and regulation. Physiol Rev 81: 629-683.
22. Han DD, Gu HH (2006). Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol 6: 6.
23. Harris DS, Baggott M, MenDelson JH, MenDelson JE, Jones RT (2002). Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology (Berl) 162: 396-405.
24. Heinrichs M, Baumgartner T, Kirschbaum C, Ehlert U (2003). Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol Psychiatry 54: 1389-1398.
25. Higgins ST,Stitzer ML,1988, Time allocation in a concurrent schedule of social interaction and monetary reinforcement: Effects of d-amphetamine, Pharmacol Biochem Behav,31, 227-231.
26. Hysek CM, Domes G, Liechti ME (2012). MDMA enhancesmind readingof positive emotions and impairsmind readingof negative emotions. Psychopharmacology (Berl) 222: 293-302.
27. Hysek CM, Liechti ME (2012). Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidin e, carvedilol, and doxazosin on pupillary light reflex. Psychopharmacology (Berl) 224: 363-376.
28. Jones BT, Jones BC, Thomas AP, Piper J (2003). Alcohol consumption increases attractiveness ratings of opposite -sex faces: A possible third route to risky sex. Addiction 98: 1069-1075.
29. Justice AJ, De Wit H (2000). Acute effects of d-amphetamine during the early and late follicular phases of the menstrual cycle in women. Pharmacol Biochem Behav 66: 509-515.
30. Kelly BC, Parsons JT, Wells BE (2006). Prevalence and predictors of club drug use among club-going young adults in New York city. J Urban Health 83: 884-895.
31. Kirkpatrick MG, De Wit H (2013). In the company of others: Social factors alter acute alcohol effects. Psychopharmacology (Berl) 230: 215-226.
32. Kirkpatrick MG, GunDerson EW, Johanson CE, Levin FR, Foltin RW, Hart CL (2012). Comparison of intranasal methamphetamine and d-amphetamine self-administration by humans. Addiction 107: 783-791.
33. Kosfeld M, Heinrichs M, Zak PJ, Fischbacher U, Fehr E (2005). Oxytocin increases trust in humans. Nature 435: 673-676.
34. Lim MM, Young LJ (2006). NeuropeptiDergic regulation of affiliative behavior and social bonding in animals. Horm Behav 50: 506-517.
35. MacDonald E, Dadds MR, Brennan JL, Williams K, Levy F, Cauchi AJ (2011). A review of safety, siDe-effects and subjective reactions to intranasal oxytocin in human research. Psychoneuro endocrinology 36: 1114-1126.
36. Macdonald K, Feifel D (2013). Helping oxytocin Deliver: ConsiDerations in the Development of oxytocin-based therapeutics for brain disorDers. Front Neurosci 7: 35.
37. Macdonald K, Macdonald TM (2010). The peptiDe that binds: A systematic review of oxytocin and its prosocial effects in humans. Harv Rev Psychiatry 18: 1-21.
38. Marsh AA, Yu HH, Pine DS, Blair RJ (2010). Oxytocin improves specific recognition of positive facial expressions. Psychopharmacology (Berl) 209: 225-232.
39. McGregor IS, Bowen MT (2012). Breaking the loop: Oxytocin as a potential treatment for drug addiction. Horm Behav 61: 331-339.
40. Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Martin SF, Yazar-Klosinski B et al (2013). Durability of improvement in post-traumatic stress disorDer symptoms and absence of harmful effects or drug DepenDency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: A prospective longterm follow-up study. J Psychopharmacol 27: 28-39.
41. Norman GJ, Cacioppo JT, Morris JS, Malarkey WB, Berntson GG, Devries AC (2011). Oxytocin increases autonomic cardiac control: MoDeration by loneliness. Biol Psychol 86: 174-180.
42. Owen SF, TuncDemir SN, BaDer PL, Tirko NN, Fishell G, Tsien RW (2013). Oxytocin enhances hippocampal spike transmission by modulating fast-spiking interneurons. Nature 500: 458-462.
43. Ramos L, Hicks C, Kevin R, Caminer A, Narlawar R, Kassiou M et al (2013). Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3,4-methylenedioxymethamphetamine in rats: Involvement of the V1A receptor. Neuropsychopharmacology 38: 2249-2259.
44. Rodgers J, Buchanan T, Pearson C, Parrott AC, Ling J, Hefferman TM et al (2006). Differential experiences of the psychobiological sequelae of ecstasy use: Quantitative and qualitative data from an internet study. J Psychopharmacol 20: 437-446.
45. Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI et al (2001). Amphetamine-type central nervous syste m stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse 39: 32-41.
46. Shahrestani S,Kemp AH,Guastella AJ, 2013, The impact of a single administration of intranasal oxytocin on the recognition of basic emotions in humans: A meta-analysis. Neuropsychopharmacology.
47. Shahrokh DK, Zhang TY, Diorio J, Gratton A, Meaney MJ (2010). Oxytocin-dopamine interactions mediate variations in maternal behavior in the rat. Endocrinology 151: 2276-2286.
48. Shamay-Tsoory SG, Fischer M, Dvash J, Harari H, Perach-Bloom N, Levkovitz Y (2009). Intranasal administration of oxytocin increases envy and schaDenfreuDe ( gloating). Biol Psychiatry 66: 864-870.
49. Sumnall HR, Cole JC, Jerome L (2006). The varieties of ecstatic experience: An exploration of the subjective experiences of ecstasy. J Psychopharmacol 20: 670-682.
50. Tallarida RJ, Murray RB (1981). Manual of Pharmacologic Calculations. Springer: HeiDelberg, Germany.
51. Tancer M, Johanson CE (2003). Reinforcing, subjective, and physiological effects of MDMA in humans: A comparison with d-amphetamine and mCPP. Drug Alcohol Depend 72: 33-44.
52. Thompson MR, Callaghan P D, Hunt GE, Cornish JL, McGregor IS (2007). A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine (?ecstasy). Neuroscience 146: 509-514.
53. van Ijzendoor n MH, Bhandari R, van Der Veen R, Grewen KM, Bakermans-Kranenburg MJ (2012). Elevated salivary levels of oxytocin persist more than 7 h after intranasal administration. Front Neurosci 6: 174.
54. Verrico CD , Miller GM, Madras BK (2007). MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: Implications for MDMA-induced neurotoxicity and treatment. Psychopharmacology (Berl) 189: 489-503.
55. Vincent PA, Etgen AM (1993). Steroid priming promotes oxytocininduced norepinephrine release in the ventromedial hypothalamus of female rats. Brain Res 620: 189-194.
56. Wardle MC, De Wit H (2012). Effe cts of amphetamine on reactivity to emotional stimuli. Psychopharmacology (Berl) 220: 143-153.
57. White TL, Justice AJ, De Wit H (2002). Differential subjective effects of D-amphetamine by genDer, hormone levels and menstrual cycle phase. Pharmacol Biochem Behav 73: 729-741.
58. Yoshida M, Takayanagi Y, Inoue K, Kimura T, Young LJ, Onaka T et al (2009). EviDence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice. J Neurosci 29: 2259-2271.
59. Young AW, Rowland D, CalDer AJ, Etcoff NL, Seth A, Perrett DI (1997). Facial expression megamix: Tests of dimensional and category accounts of emotional recognition. Cognition 63: 271-313.
60. Zak PJ, Stanton AA, Ahmadi S (2007). Oxytocin increases generosity in humans. PLoS ONE 2: E1128.